HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.

Abstract
Integrins alphavbeta3 and alphavbeta5 are overexpressed in angiogenic tumor endothelial cells and malignant tumor cells, making them attractive targets for cancer therapy. In this study, an integrin alphavbeta3 and alphavbeta5 binding tripeptide, RGD (Arg-Gly-Asp), was conjugated with the surface of poly(ethylene glycol)-block-poly(D,L-lactide) (PEG-PLA) micelles. A lipophilic fluorescent probe, DiI, was loaded into both the nontargeted methoxy PEG-PLA (mPEG-PLA) micelles and the targeted RGD-modified PEG-PLA micelles. The DiI-loaded targeted micelles had a size of 24.2 nm. The targeted micelles were stable in phosphate buffered saline and exhibited a negligible leakage in culture medium. Transmission electron microscopy analysis showed that targeted micelles were spherical in shape. Cell uptake of DiI-labeled targeted micelles by human umbilical vein endothelial cells and melanoma B16 cells was investigated by spectrophotofluorometry and confocal microscopy techniques. Results revealed that RGD-modified micelles significantly facilitated the intracellular delivery of the encapsulated agents via integrin-mediated endocytosis. This study suggests that RGD-modified PEG-PLA micelles are promising drug carriers for targeted delivery to both angiogenic tumor endothelial cells and tumor cells and that the targeted micelles may be attractive carriers for combination cancer therapy against both targets.
AuthorsYiguang Wang, Xun Wang, Yifei Zhang, Shijin Yang, Jiancheng Wang, Xuan Zhang, Qiang Zhang
JournalJournal of drug targeting (J Drug Target) Vol. 17 Issue 6 Pg. 459-67 (Jul 2009) ISSN: 1029-2330 [Electronic] England
PMID19527117 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Drug Carriers
  • Integrin alphaVbeta3
  • Micelles
  • Oligopeptides
  • Receptors, Vitronectin
  • integrin alphaVbeta5
  • monomethoxypolyethyleneglycol-polylactide block copolymer
  • Polyethylene Glycols
  • arginyl-glycyl-aspartic acid
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, chemistry, pharmacokinetics)
  • Cell Line, Tumor
  • Cells, Cultured
  • Drug Carriers (chemistry)
  • Drug Delivery Systems
  • Endothelium, Vascular (metabolism)
  • Humans
  • Integrin alphaVbeta3 (genetics, metabolism)
  • Melanoma (drug therapy, metabolism)
  • Mice
  • Micelles
  • Neovascularization, Pathologic (drug therapy)
  • Oligopeptides (administration & dosage, chemistry, pharmacokinetics)
  • Polyethylene Glycols (chemistry)
  • Receptors, Vitronectin (genetics, metabolism)
  • Umbilical Veins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: